Skip to main content

Kabiven / Perikabiven

Generic name: Date of Approval: August 25, 2014
Drug class: Intravenous nutritional products
Company: Fresenius Kabi USA

Treatment for: Parenteral Nutrition

FDA Approves Kabiven and FDA Approves Perikabiven

The U.S. Food and Drug Administration has approved Kabiven and Perikabiven (amino acids, electrolytes, dextrose and lipid injectable emulsion) parenteral nutrition (PN) products in a three-chamber bag. The unique three-chamber bag simplifies the delivery of parenteral nutrition by providing a premixed solution that is shelf-stable until activated for patient use.

Indications and Limitations of Use

Important Safety Information


Warnings and Precautions

To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC, Vigilance & Medical Affairs at 1-800-551-7176 or FDA at 1-800-FDA-1088 or

Please see full Prescribing Information, including Boxed Warning, for Kabiven and Perikabiven.

Patient Counseling Information for Kabiven

Patient Counseling Information for Perikabiven

More about Kabiven (parenteral nutrition solution w/electrolytes)

Patient resources

Other brands


Professional resources

Other brands

Perikabiven, Procalamine

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.